In this regard, a recent study has documented the ability of fucoidans to inhibit VEGF-induced angiogenesis and tumor neovascularization in vivo, likely through modulation of cell surface neuropilins (NRP1 or NRP2) and other VEGF receptors [19]. This evidence concerns the gene NRP1 and neoplasm.